Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation


Acronyms Definitions
BLT-D Biaxin, Low dose thalidomide, dexamethasone
ß2M Beta 2 Microglobulin
CBC Complete Blood Count
CR Complete Remission
CRP C-Reactive Protein
C-VAMP VAMP + Cyclophosphamide
DEX Dexamethasone
DCEP Dexamethasone, Cyclophosphamide, Etoposide and Cisplatin
DCEP-T Dexamethasone, Cyclopsospamide, Etoposide, Cisplatin & Thalidomide
DPACE Dexamethasone, Cisplatin, Adriamycin, Cyclophosphamide, Etoposide
DT-PACE Dexamethasone, Thalidomide, Cisplatin, Adriamycin, Cyclophosphamide, Etoposide
DVD Doxil, Vincristine, Dex
DVT Deep Vein Thrombosis
DVD-T Doxil, Vincristine, Dex & Thalidomide
EFS Event Free Survival
FISH Fluorescent In Situ Hybridization
GVHD Graft Versus Host Disease
HDT High Dose Therapy
IMM Indolent Multiple Myeloma
ISS International Staging System
MGUS Monoclonal Gammapathy of Undetermined Significance
MP Melphalan & Prednisone
MRI Magnetic Resonance Imaging
ONJ Osteonecrosis of the Jaw
OS Overall survival
PET Positron Emission Tomography
PN Peripheral Neuropathy
PR Partial Remission
PSCT Peripheral Stem Cell Transplant
REVLoDEX Revlimid, Low dose Dexamethasone
SCT Stem Cell Transplant
SMM Smouldering Multiple Myeloma
SRE Skeletal Related Event
TMI Too Much Information
TTP Time to Progression
VAD Vincristine, Adriamycin, Dexamethasone
VAMP Vincristine, Adriamycin, Methyl prednisone
VEGF Vascular Endothelial Growth Factor
VGPR Very Good Partial Remission